cyclosporine vs infliximab

According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.

Side-by-side comparison of cyclosporine and infliximab. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.

minor Known Drug Interaction

Upon initiation or discontinuation of INFLECTRA in patients being treated with CYP450 substrates with a narrow therapeutic index, monitoring of the effect (e.g., warfarin) or drug concentration (e.g., cyclosporine or theophylline) is recommended and the individual dose of the drug product may be adjusted as needed.

Drug Class
cyclosporine Calcineurin Inhibitor (Immunosuppressant)
infliximab TNF-Alpha Inhibitor (Biologic)
Type
cyclosporine Prescription
infliximab Prescription
Summary
cyclosporine

Vevye eye drops contain cyclosporine. They help treat the signs and symptoms of dry eye disease.

infliximab

Inflectra is a medicine that blocks a protein called TNF. It is used to treat autoimmune diseases and reduce inflammation.

What It Treats
cyclosporine

Vevye treats the signs and symptoms of dry eye disease. Dry eye can cause discomfort, stinging, and blurred vision. This medicine can help reduce these symptoms.

infliximab

Inflectra treats Crohn's disease in adults and children (6+). It helps reduce symptoms and keep the disease under control. It also treats ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

How It Works
cyclosporine

Vevye contains cyclosporine, which is an immunosuppressant. It works by decreasing inflammation in the eyes. This helps your eyes make more tears.

infliximab

Inflectra blocks a protein in your body called tumor necrosis factor (TNF). TNF can cause inflammation and damage in autoimmune diseases. By blocking TNF, Inflectra can reduce inflammation and improve symptoms.

Common Side Effects
cyclosporine
  • Irritation where the drops are applied (8%)
infliximab
  • Infections (like colds, sinus infections, and sore throat)
  • Infusion-related reactions
  • Headache
  • Abdominal pain
FAERS Reports
cyclosporine
  • Eye Irritation 7,786
  • Pyrexia 4,064
  • Eye Pain 3,808
  • Nausea 3,623
  • Diarrhoea 3,562
infliximab
  • Infusion Related Reaction 18,648
  • Condition Aggravated 18,301
  • Rheumatoid Arthritis 18,136
  • Pain 18,107
  • Arthralgia 16,853
Serious Warnings
cyclosporine

To avoid eye injury or contamination, do not touch the bottle tip to your eye or any other surface. Do not use Vevye while wearing contact lenses. If you wear contacts, remove them before using the drops. You can put them back in 15 minutes after using Vevye.

infliximab

Inflectra can increase your risk of serious infections that may lead to hospitalization or death. Tell your doctor if you have any infection symptoms. You should be tested for tuberculosis (TB) before starting Inflectra. Some people, especially children and young adults, have developed cancers like lymphoma while taking TNF blockers. Some of these cancers have been fatal.

Pregnancy
cyclosporine

It is not known if Vevye will harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. Cyclosporine can pass into breast milk after being taken orally, but it is unknown if it passes into breast milk from eye drops. Talk to your doctor if you are breastfeeding.

infliximab

Tell your doctor if you are pregnant or plan to become pregnant. Inflectra can pass to your baby during pregnancy, mainly in the third trimester. Live vaccines are not recommended for at least 6 months after birth for babies exposed to Inflectra in the womb.

Also Compare, Nearby Drugs

How to Read This cyclosporine vs infliximab Comparison

cyclosporine is classified in the Calcineurin Inhibitor (Immunosuppressant) drug class, while infliximab sits within the TNF-Alpha Inhibitor (Biologic) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.

Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, cyclosporine has 22,843 submissions while infliximab has 90,045. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to infliximab may affect the liver enzymes that process cyclosporine, which could change the amount of medicine in your system.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.

A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for cyclosporine or infliximab.

Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.